FDA Issues Guidance On IDEs For Knee Cartilage Replacement
This article was originally published in The Gray Sheet
Executive Summary
Investigational device exemption (IDE) applications for knee cartilage replacement products should include a detailed product description, manufacturing and packaging methodology, and nonclinical testing data to assess biological responses and toxicology, FDA advises in a July 9 1draft guidance